Cite
HARVARD Citation
Micheletto, M. et al. (2021). Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice. International journal of experimental pathology. 102 (1), pp. 11-21. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Micheletto, M. et al. (2021). Ixazomib, an oral proteasome inhibitor, exhibits potential effect in dystrophin‐deficient mdx mice. International journal of experimental pathology. 102 (1), pp. 11-21. [Online].